NEW YORK, NY / ACCESSWIRE / March 16, 2016 / DelMar Pharmaceuticals, Inc. (OTCQX: DMPI) today published a new blog post on The Chairman's Blog, written by the Company's Chief Executive Officer, Jeffrey Bacha. TheChairmansBlog.com is an exclusive online media publication that enables key executive officers a unique platform to share insights about their company and industry trends.
In his new blog, DelMar CEO Jeffrey Bacha discusses the different paths small biotech companies can take to fund drug development and bring the treatment to patients: licensing partnerships and "going it alone." He highlights what he feels are the three key elements a Company must have in order to pursue independent commercialization, and discusses companies such as Celgene who have successfully used this approach. Mr. Bacha goes on to highlight how this approach has the potential to unlock significant shareholder value, and how he believes DelMar has the qualities to independently develop VAL-083 for glioblastoma multiforme and bring it to market. Read the full blog post from Mr. Bacha on TheChairmansBlog.com (http://www.thechairmansblog.com/delmar-pharmaceuticals/jeffrey-bacha/unlocking-the-value-of-independent-commercialization-2/).
About DelMar Pharmaceuticals, Inc.
DelMar Pharmaceuticals, Inc. was founded to develop and commercialize new cancer therapies in indications where patients are failing or have become intolerable to modern targeted or biologic treatments. The Company's lead drug in development, VAL-083, is currently undergoing clinical trials in the U.S. as a potential treatment for refractory glioblastoma multiforme. VAL-083 has been extensively studied by U.S. National Cancer Institute, and is currently approved for the treatment of chronic myelogenous leukemia and lung cancer in China. Published pre-clinical and clinical data suggest that VAL-083 may be active against a range of tumor types via a novel mechanism of action that could provide improved treatment options for patients.
About TheChairmansBlog.com
TheChairmansBlog.com is an exclusive, online media publication where publicly and privately held firms alike share insights about their companies and industries. TheChairmansBlog.com enables upper tier management to discuss issues that are of importance to their stakeholders, shareholders, and interested parties in an informal environment. www.thechairmansblog.com
SOURCE: TheChairmansBlog.com
